Desferrioxamine to improve cardiac function in iron-overloaded patients with thalassemia major

Lancet. 1984 Feb 18;1(8373):392-3. doi: 10.1016/s0140-6736(84)90439-2.
No abstract available

Publication types

  • Letter

MeSH terms

  • Deferoxamine / therapeutic use*
  • Heart Diseases / chemically induced
  • Heart Diseases / drug therapy*
  • Humans
  • Iron / adverse effects*
  • Thalassemia / therapy*
  • Transfusion Reaction

Substances

  • Iron
  • Deferoxamine